Skba Capital Management LLC Gilead Sciences, Inc. Transaction History

Skba Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $6.14 Million - $7 Million	-108,400 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $444,015 - $558,272	-7,150 Reduced 6.19%	108,400 $6.85 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $97,659 - $113,400	-1,350 Reduced 1.15%	115,550 $8.89 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $3.65 Million - $4.67 Million	-58,200 Reduced 33.24%	116,900 $8.74 Million
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $1.01 Million - $1.11 Million	-16,400 Reduced 8.56%	175,100 $11.4 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $1.37 Million - $1.51 Million	21,900 Added 12.91%	191,500 $12.1 Million
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $197,984 - $222,016	-3,200 Reduced 1.85%	169,600 $11.5 Million
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $703,462 - $788,062	-11,250 Reduced 6.11%	172,800 $11.2 Million
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $823,344 - $1.07 Million	-13,600 Reduced 6.88%	184,050 $11.5 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $103,808 - $121,088	-1,600 Reduced 0.8%	197,650 $14 Million
Q1 2018 May 08, 2018	BUY	$72.84 - $88.8 $36,420 - $44,400	500 Added 0.25%	199,250 $15 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $2.6 Million - $3.06 Million	36,600 Added 22.57%	198,750 $14.2 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $11.7 Million - $13.9 Million	162,150	162,150 $13.1 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Skba Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Skba Capital Management LLC with notifications on news.